Molecules known for their anticancer activity have proven effective against Plasmodium falciparum, the parasite that causes malaria. Researchers at the University of São Paulo's School of Pharmaceutical Sciences (FCF-USP) ...
Sep 29, 2026
0
5
When someone buys a drug illegally, they cannot be sure exactly what is in it.
Sep 24, 2026
0
5
Southwest Research Institute (SwRI) is using a generative artificial intelligence (AI) tool to improve pharmaceutical development outcomes. The SwRI-developed GAMES, or Generative Approaches for Molecular Encodings, uses ...
Sep 30, 2026
0
5
The battle lines have finally shifted in the war against a deadly fungal disease.
Sep 30, 2026
0
4
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
4
For millions of people around the world, managing a long-term health condition means remembering to take medicines every day, often for years. But advances in long-acting medicines mean that some treatments now need to be ...
Sep 30, 2026
0
4
Researchers from Mass General Brigham and the University of Cyprus have developed a mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy ...
Sep 30, 2026
0
3
Federal prosecutors have charged two people in an alleged scheme to bring fake versions of the type 2 diabetes drug Ozempic from China and sell them to U.S. distributors.
Sep 30, 2026
0
3
More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
9 hours ago
0
3
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1 receptor agonist (GLP-1 RA) drugs in children ...
Sep 30, 2026
0
2
